[144] XPO, Inc. SEC Filing

Rhea-AI Filing Summary

XPO, Inc. filed a Form 144 Notice indicating a proposed sale of 3,250 common shares through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $438,869.93. The filing shows the shares were issued as restricted stock: 1,090 shares acquired 01/02/2024 and 2,160 shares acquired 01/02/2025, with payment dates matching acquisition dates and described as Not Applicable for non-cash consideration. The filer reports 117,762,083 shares outstanding for the issuer and notes no securities sold in the past three months by the reporting person. The notice includes the required attestation that the seller is not aware of undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: Routine Rule 144 filing for a small insider sale; provides transparency but appears immaterial to company valuation.

The Form 144 documents a proposed sale of 3,250 shares with an aggregate market value of $438,869.93 executed through Morgan Stanley Smith Barney on the NYSE. The shares were received as restricted stock in two tranches on 01/02/2024 and 01/02/2025. The filing discloses total outstanding shares of 117,762,083, which implies the proposed sale represents a very small fraction of outstanding stock. There are no reported sales by the filer in the prior three months. From a market-impact perspective this notice is primarily a compliance and disclosure item rather than a material corporate event.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure showing vested restricted shares being offered for sale; attestation included as required.

The form shows the seller acquired the securities as restricted stock from the issuer and is following Rule 144 procedures by filing this notice. The filing includes the standard attestation that the seller is unaware of any undisclosed material adverse information. There are no indications in the filing of plan adoption dates or 10b5-1 instructions. This appears to be routine insider reporting consistent with governance and disclosure obligations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3250	438869.93	117762083	09/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/02/2024	Restricted Stock	Issuer			1090	01/02/2024	Not Applicable
Common	01/02/2025	Restricted Stock	Issuer			2160	01/02/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does XPO's Form 144 report?

The filing reports a proposed sale of 3,250 common shares via Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $438,869.93.

When were the shares acquired for the XPO sale reported in Form 144?

The shares were acquired as restricted stock on 01/02/2024 (1,090 shares) and 01/02/2025 (2,160 shares).

How many XPO shares are outstanding according to the filing?

The filing lists 117,762,083 shares outstanding for the issuer.

Has the filer sold any XPO securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

What attestation does the filer make in the Form 144?

The filer attests they do not know any material adverse information about the issuer that has not been publicly disclosed, per the Form 144 signature block.